Europe’s oligonucleotide landscape is entering a pivotal growth phase. With the €21M launch of Aerska and major collaborations such as Novartis and SciNeuron, Lundbeck and Contera, and Secarna and Vect-Horus, European biopharma are rapidly advancing RNA-targeted approaches to address previously undruggable CNS diseases.

Venue details: Novotel Amsterdam Schiphol Airport, 12 Taurusavenue, Hoofddorp, Noord-Holland, 2132 LS, Netherlands

Prices: EUR 2099.00 to EUR 4797.00

Time: 08:00 to 16:00